Priority Date: 26.05.11 (EP 20110382172)

SOLUBLE PROTEIN CD5 OR CD6 FOR THE TREATMENT OF CANCER OR TUMOR OR FOR USE AS AN ADJUVANT

  • Application ID: EP12726052
  • Status: PATENT GRANTED

Applicants

Research organisation logo small
Research Organisation

Attorney

Employment test 51 - 200 employees
Company dna hoffmann eitle
operating since 1892
Headquarter in Munich and 4 offices
active in Legal Services and IP Portfolio Processing

Specialization

This patent has the IPC combination A01, A61, and C12 is specialized in the combination A01, A61, and C12. We found, that Sperling Fischer & Heyner, Zacco Denmark A/S, Isenbruck Bösl Hörschler LLP, Uexküll & Stolberg Partnerschaft von Patent- und Rechtsanwälten mbB, dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB and 35 others are specialized in all of these IPC classes. For a similar patent, they might be a good choice.

Timeline

  • 26.05.2011 - Priority Date (EP 20110382172)
  • 29.11.2012 - Publication A1 (WO2012160215)
  • 09.04.2014 - Publication A1 (EP2714066)
  • 05.04.2017 - Publication B1 (EP2714066)